Evidence map›Paper›PMID 33185837›Full record

ArticleStem cell reviews and reports2021

Interleukin-8 Receptors CXCR1 and CXCR2 Are Not Expressed by Endothelial Colony-forming Cells.

Adeline Blandinières, Xuechong Hong, Aurélien Philippe, Ivan Bièche, Sophie Vacher, Elisa Rossi, Grégoire Detriche, Nicolas Gendron, Pascale Gaussem, Coralie L Guerin and 2 more

Open access · greenAbstract read
In one paragraph

Article in Stem cell reviews and reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 82% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 7 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Adeline BlandinièresInnovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006 , Paris, France.
Xuechong HongDepartment of Cardiac Surgery, Boston Children's Hospital, Boston, MA, USA.
Aurélien PhilippeInnovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006 , Paris, France.
Ivan BiècheDepartment of Genetics, Université de Paris and Pharmacogenomics Unit, Institut Curie, Paris, France.
Sophie VacherDepartment of Genetics, Université de Paris and Pharmacogenomics Unit, Institut Curie, Paris, France.
Elisa RossiInnovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006 , Paris, France.
Grégoire DetricheInnovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006 , Paris, France.
Nicolas GendronInnovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006 , Paris, France.
Pascale GaussemInnovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006 , Paris, France.
Coralie L GuerinInnovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006 , Paris, France.
Juan M Melero-MartinDepartment of Cardiac Surgery, Boston Children's Hospital, Boston, MA, USA.
David M SmadjaInnovative Therapies in Haemostasis, INSERM, Université de Paris, F-75006 , Paris, France. david.smadja@aphp.fr.ORCID 0000-0001-7731-9202
Inserm · FRBoston Children's Hospital · USInstitut Curie · FR

Funding

Vascular networks genetically engineered for protein drug deliveryR01HL128452 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI MELERO-MARTIN, JUAN M, WANG, BO · 2015 to 2024
$4.8M
Vascular niche bioengineering for human bone regenerationR01AR069038 · NIAMS · BOSTON CHILDREN'S HOSPITAL · PI MELERO-MARTIN, JUAN M · 2016 to 2020
$1.9M
NHLBI NIH HHS R01 HL128452NIAMS NIH HHS R01 AR069038
6 · The paper itself

Abstract

Endothelial colony-forming cells (ECFCs) are human vasculogenic cells described as potential cell therapy product and good candidates for being a vascular liquid biopsy. Since interleukin-8 (IL-8) is a main actor in senescence, its ability to interact with ECFCs has been explored. However, expression of CXCR1 and CXCR2, the two cellular receptors for IL-8, by ECFCs remain controversial as several teams published contradictory reports. Using complementary technical approaches, we have investigated the presence of these receptors on ECFCs isolated from cord blood. First, CXCR1 and CXCR2 were not detected on several clones of cord blood- endothelial colony-forming cell using different antibodies available, in contrast to well-known positive cells. We then compared the RT-PCR primers used in different papers to search for the presence of CXCR1 and CXCR2 mRNA and found that several primer pairs used could lead to non-specific DNA amplification. Last, we confirmed those results by RNA sequencing. CXCR1 and CXCR2 were not detected in ECFCs in contrary to human-induced pluripotent stem cell-derived endothelial cells (h-iECs). In conclusion, using three different approaches, we confirmed that CXCR1 and CXCR2 were not expressed at mRNA or protein level by ECFCs. Thus, IL-8 secretion by ECFCs, its effects in angiogenesis and their involvement in senescent process need to be reanalyzed according to this absence of CXCR-1 and - 2 in ECFCs.Graphical Abstract.

Indexed as

Endothelial CellsFetal BloodHumansReceptors, Interleukin-8AReceptors, Interleukin-8BCXCR2 protein, humanReceptors, Interleukin-8AReceptors, Interleukin-8BchemokinesCXCR1CXCR2ECFCsinterleukin-8RNAseq

Identifiers

PMID33185837
PMCPMC8337095
OpenAlexW3098567702

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.